Products and Services
-
Aptar Pharma has announced a deal with French biotech Aceso Therapeutics related to development of Aceso’s ACT-101 antisense oligonucleotide for the treatment of cystic fibrosis. According to Aptar, its subsidiary Nanopharm will provide development services… Read more . . .
-
Inhaler testing specialist Copley Scientific has announced the launch of its new Inhalytix+ v2.0 and Critical Flow Controller TPK 200iX. The company launched Version 1 of Inhalytix+, a subscription-based cascade impactor software package, in August 2025. The TPK… Read more . . .
-
Drug delivery specialist Nemera has announced the launch of a new bidose nasal spray platform called DuoSpray that is intended for delivery of systemic drugs, including CNS therapies. The company says that the customizable intranasal… Read more . . .
-
Inhalation specialist CDMO Bespak announced that its Holmes Chapel, UK site has again received a Gold EcoVadis sustainability rating, the second since Bespak was spun out from Recipharm in 2024. Earlier this year, Bespak and… Read more . . .
-
According to Aptar Pharma, parent company of OINDP-focused CRO Nanopharm, the UK Medicines and Healthcare Products Regulatory Agency has completed an inspection of Nanopharm’s facility in Cwmbran, Wales and has certified the location as GMP compliant.… Read more . . .
-
Dutch CDMO Basic Pharma announced that German investment firm SHS Capital has acquired a majority stake in the company, with the investment expected to support additional manufacturing capacity. The announcement highlights Basic Pharma’s development and… Read more . . .
-
According to Texas-based CDMO Matica Biotechnology, the company will provide development and manufacturing services to vaccine developer VaxDome, also based in Texas, to advance a VaxDome intranasal antiviral / vaccine candidate into clinical trials. Matica… Read more . . .
-
Nebulizer developer Nebu-Flow, which recently received a £2 million Scottish Enterprise grant, announced that it has been invited to join the Innovate UK Scaleup Programme, which will provide access to a “virtual executive team.” The… Read more . . .
-
According to DPI developer Iconovo, the company has now signed a strategic collaboration deal with CDMO Lonza for development of spray dried formulation of inhaled biologics. In January 2025, Iconovo said that Lonza would develop spray dried… Read more . . .
-
University of Glasgow spin-out Nebu~Flow has received a Scottish Enterprise grant worth £2 million “to accelerate development and patient access to its patented nebulizer technology in the UK and globally,” the company said. The company… Read more . . .
Featured event:

Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 21-October 22: MVIC Symposium, Lund, Sweden
October 28-October 30: Deutches Aerosol Therapie Symposium (DATS), Marburg, Germany
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland



